Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06709846

Magnetic Resonance Imaging in Metabolic Diseases

This study aims to leverage structural, functional, and metabolic magnetic resonance imaging (MRI) of the brain to identify imaging features that correlate with clinical parameters. It is hypothesized that individuals with metabolic diseases exhibit distinct functional and structural brain differences compared to healthy controls. These differences may evolve over time due to changes in whole-body metabolism or body weight, influenced by factors such as the natural progression of the disease or therapeutic interventions. Additionally, potential brain changes may correlate with body composition metrics, such as the fat content of specific body compartments.

This is a prospective, single-center study conducted at Ulm University Hospital, designed to track the clinical and imaging histories of patients with metabolic diseases and compare them to healthy individuals. Eligible participants include adults (aged 18 and older) capable of providing informed consent. Recruitment will occur through routine clinical care or existing research studies. To provide a comprehensive understanding, the study will include both cross-sectional analyses and longitudinal follow-up of participants, integrating repeated assessments during routine medical visits.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with metabolic diseases OR
  • healthy control participants without metabolic diseases
  • written consent

Exclusion criteria

  • History of traumatic brain injuries
  • preterm birth (≤34th week of pregnancy) of the study participant
  • history of brain surgery
  • structural brain changes (e.g., tumors, congenital abnormalities, etc.)
  • neurological developmental disorders (e.g., autism spectrum disorders, learning disabilities, intellectual disability)
  • epilepsy,
  • drug addiction
  • other severe neurological or severe psychiatric disorders (e.g., schizophrenia
  • pregnancy
  • acute clinically relevant inflammatory diseases
  • acute systemic or local infections
  • severe or etiologically unclear diseases depending on the principle investigators judgement
  • pre-existing intellectual impairment
  • significant limitations in language comprehension
  • absence of written consent
  • general exclusion criteria for MRI imaging (e.g., pacemaker systems, neurostimulators, cochlear implants)

Treatment and study plan

Primary outcomes

  1. Structural differences in the brain between patients with metabolic diseases and healthy controls

    Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

    Comparison of brain anatomical magnetic resonance imaging sequences (T1- and T2-weighted sequences) between patients with metabolic diseases and healthy controls give insights into structural features in patients with metabolic diseases.

  2. Functional differences in the brain between patients with metabolic diseases and healthy controls

    Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

    Comparison of brain functional magnetic resonance imaging between patients with metabolic diseases and healthy controls will give insights into functional aspects of patients with metabolic diseases.

  3. Metabolic differences in the brain between patients with metabolic diseases and healthy controls

    Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

    Comparison of brain metabolic magnetic resonance imaging (Chemical Exchange Saturation Transfer (CEST)", MR-spectroscopy) between patients with metabolic diseases and healthy controls give insights into metabolic features in patients with metabolic diseases

  4. Body Composition derived from magnetic resonance imaging

    Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

    Magnetic resonance imaging (DIXON sequence or fat-water imaging to determine the "Proton Density Fat Fraction" (PDFF)) will be used to determine the fat content in the different compartments of the whole body.

Study contacts

Contact information is provided by the study sponsor or research team.

Martin Heni, Prof. Dr. med.

CONTACT

[email protected]

+4973150044505

Nico Sollmann, PD Dr. Dr. med.

CONTACT

[email protected]

+49 (0)731 500-61001

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Nov 29, 2024
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.